Anavex downgraded by Cantor Fitzgerald with a new price target

12/6/22 9:27:26 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Cantor Fitzgerald downgraded Anavex from Overweight to Neutral and set a new price target of $11.00 from $16.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AVXL

Date	Price Target	Rating	Analyst
12/6/2022	$16.00 → $11.00	Overweight → Neutral	Cantor Fitzgerald
6/23/2022	$40.00	Buy	Berenberg
2/2/2022	$39.00 → $42.00	Buy	HC Wainwright & Co.
9/23/2021	$35.00	Buy	BTIG Research
6/28/2021	$25.00 → $39.00	Buy	HC Wainwright & Co.